NL-OMON21916招募中不适用
ongitudinal prediction of progression in MS: 'The Amsterdam MS Cohort'
VU University Medical Center0 个研究点目标入组 260 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 260
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational non invasive
入排标准
入选标准
- •All people with MS and all healthy controls who have previously participated in the Presto (local ethics committee number: 2002/140), GeneOCT (2004/9), or LTD (2010/336) studies (collectively also known as the Amsterdam MS Cohort”) and have not provided objection to be contacted for follow-up study, or have been enquired to join the cohort based on the Amsterdam MS Cohort (2020/269) protocol.
排除标准
- •MS patients unable to undergo the minimal data collection (as described in Methods section) or comorbidity that interferes with participation in this study (controls).
研究者
相似试验
招募中
不适用
ongitudinal prediction of progression in MS: The PrograMS CohortMSDisseminated sclerosis10012303NL-OMON51918Vrije Universiteit Medisch Centrum300
进行中（未招募）
Unknown
Identifying genetic determinants of outcome in multiple sclerosisNervous System DiseasesMultiple sclerosisISRCTN41688895Cambridge University Hospitals NHS Foundation Trust10,000
已完成
不适用
Predictive markers for progessive disease progression in Acne Inversa (AI)/Hidradentitis Suppurativa (HS) patientsACNEINVERSAL73L73.2Other follicular disordersHidradenitis suppurativaDRKS00013778AbbVie Deutschland GmbH Co. KG481
已完成
不适用
Does MS grey matter atrophy progress faster in regions with more damage in connected white matter?10012303multiple sclerosisNL-OMON43307Vrije Universiteit Medisch Centrum55
已完成
不适用
Artificial Intelligence in Predicting Progression in Multiple Sclerosis StudyMultiple Sclerosis LesionMultiple Sclerosis Brain LesionMultiple SclerosisNCT05426980University of Ljubljana654